Teva's contribution to Israel's tax revenues has been virtually zero.
Neither bad timing nor business necessity excuse the mistake over Actavis, writes Avishai Ovadia.
"Globes" visited the impressively designed airport, which can serve 4.25 million passengers a year.
LogMeIn got more than it thought it was getting when it acquired Israeli company Nanorep.
The paradox of Israel's apparently booming economy combined with poverty stems from the mechanism of so-called growth.
As Teva workers await the axe, one tells "Globes" that he fears he will be shortchanged while outgoing CSO Michael Hayden gets $2.5 million by the end of 2018.
S&P Maalot nevertheless sees the medium-term trend as likely to be upwards.